Clinical Trials

Portopulmonary hypertension

Displaying 3 studies

PORtopulmonary Hypertension Treatment wIth maCitentan ─ a randOmized Clinical Trial Jacksonville, FL

24-week study to evaluate the efficacy and safety of macitentan for the treatment of portopulmonary hypertension.
PORtopulmonary Hypertension Treatment wIth maCitentan ─ a randOmized Clinical Trial Scottsdale/Phoenix, AZ

24-week study to evaluate the efficacy and safety of macitentan for the treatment of portopulmonary hypertension.
A Study to Evaluate Pulmonary Vascular Complications of Liver Disease 3 (PVCLD3) Rochester, MN

The purpose of this study is toexamine whether increased sphingosine 1 phosphate : ceramide ratio and circulating bile acids are associated with HPS in patients with advanced liver disease.